Briqulimab

Briqulimab Phase I Study Doses First Patient With Lower-Risk MDS | Pharmtales

Briqulimab Phase I Study Doses First Patient With Lower-Risk MDS

SG Tylor

Source – Jasper Therapeutics Jasper Therapeutics has initiated a Phase I trial (NCT05903274)  to evaluate the use of briquilimab  as ...